A Study of Prexasertib (LY2606368), CHK1 Inhibitor, and LY3300054, PD-L1 Inhibitor, in Patients With Advanced Solid Tumors
Clinical trial NCT03495323 · COMPLETED
Trial details
- NCT number
- NCT03495323
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-16
- Primary completion
- 2021-02-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.